Ami Fadia
Stock Analyst at HC Wainwright & Co.
(4.00)
# 596
Out of 5,005 analysts
392
Total ratings
46.63%
Success rate
13.01%
Average return
Main Sectors:
Stocks Rated by Ami Fadia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMRX Immuneering | Reiterates: Buy | $11 | $6.05 | +81.82% | 20 | Sep 30, 2025 | |
| MRUS Merus | Downgrades: Hold | $96 | $94.29 | +1.81% | 31 | Sep 29, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Buy | $30 → $28 | $21.80 | +28.44% | 11 | Sep 24, 2025 | |
| HRMY Harmony Biosciences Holdings | Maintains: Buy | $48 → $41 | $27.28 | +50.29% | 38 | Sep 24, 2025 | |
| BIIB Biogen | Reiterates: Hold | n/a | $159.88 | - | 43 | Sep 24, 2025 | |
| NBIX Neurocrine Biosciences | Maintains: Buy | $161 → $170 | $137.03 | +24.06% | 15 | Sep 22, 2025 | |
| RVMD Revolution Medicines | Maintains: Buy | $56 → $66 | $46.71 | +41.30% | 26 | Sep 11, 2025 | |
| JAZZ Jazz Pharmaceuticals | Reiterates: Buy | $202 | $139.48 | +44.82% | 34 | Aug 28, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $18 → $16 | $7.95 | +101.26% | 21 | Aug 6, 2025 | |
| AXSM Axsome Therapeutics | Reiterates: Buy | $150 | $120.30 | +24.69% | 16 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $31.06 | +44.88% | 3 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $15.76 | - | 23 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $54.38 | +47.11% | 12 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $23.23 | +50.67% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.83 | +173.22% | 9 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $15.01 | +26.58% | 36 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $29 | $8.37 | +246.48% | 20 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $240 → $320 | $18.84 | +1,598.51% | 2 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $63 → $75 | $24.84 | +201.93% | 7 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $15 → $23 | $0.67 | +3,254.70% | 4 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $63 | $22.51 | +179.88% | 5 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $12 → $5 | $5.67 | -11.82% | 2 | Jan 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $20.01 | - | 9 | Oct 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $22 | $1.32 | +1,566.67% | 4 | Jan 3, 2018 |
Immuneering
Sep 30, 2025
Reiterates: Buy
Price Target: $11
Current: $6.05
Upside: +81.82%
Merus
Sep 29, 2025
Downgrades: Hold
Price Target: $96
Current: $94.29
Upside: +1.81%
ACADIA Pharmaceuticals
Sep 24, 2025
Maintains: Buy
Price Target: $30 → $28
Current: $21.80
Upside: +28.44%
Harmony Biosciences Holdings
Sep 24, 2025
Maintains: Buy
Price Target: $48 → $41
Current: $27.28
Upside: +50.29%
Biogen
Sep 24, 2025
Reiterates: Hold
Price Target: n/a
Current: $159.88
Upside: -
Neurocrine Biosciences
Sep 22, 2025
Maintains: Buy
Price Target: $161 → $170
Current: $137.03
Upside: +24.06%
Revolution Medicines
Sep 11, 2025
Maintains: Buy
Price Target: $56 → $66
Current: $46.71
Upside: +41.30%
Jazz Pharmaceuticals
Aug 28, 2025
Reiterates: Buy
Price Target: $202
Current: $139.48
Upside: +44.82%
Day One Biopharmaceuticals
Aug 6, 2025
Maintains: Buy
Price Target: $18 → $16
Current: $7.95
Upside: +101.26%
Axsome Therapeutics
Aug 4, 2025
Reiterates: Buy
Price Target: $150
Current: $120.30
Upside: +24.69%
Jul 29, 2025
Reiterates: Buy
Price Target: $45
Current: $31.06
Upside: +44.88%
Jun 17, 2025
Reiterates: Hold
Price Target: n/a
Current: $15.76
Upside: -
Jun 12, 2025
Reiterates: Buy
Price Target: $80
Current: $54.38
Upside: +47.11%
May 28, 2025
Initiates: Buy
Price Target: $35
Current: $23.23
Upside: +50.67%
May 13, 2025
Reiterates: Buy
Price Target: $5
Current: $1.83
Upside: +173.22%
May 8, 2025
Reiterates: Buy
Price Target: $19
Current: $15.01
Upside: +26.58%
May 2, 2025
Reiterates: Buy
Price Target: $29
Current: $8.37
Upside: +246.48%
Feb 1, 2021
Maintains: Outperform
Price Target: $240 → $320
Current: $18.84
Upside: +1,598.51%
Jan 21, 2021
Downgrades: Market Perform
Price Target: $63 → $75
Current: $24.84
Upside: +201.93%
Oct 1, 2020
Maintains: Market Perform
Price Target: $15 → $23
Current: $0.67
Upside: +3,254.70%
Sep 17, 2020
Maintains: Outperform
Price Target: $64 → $63
Current: $22.51
Upside: +179.88%
Jan 30, 2019
Downgrades: Market Perform
Price Target: $12 → $5
Current: $5.67
Upside: -11.82%
Oct 1, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $20.01
Upside: -
Jan 3, 2018
Initiates: Outperform
Price Target: $22
Current: $1.32
Upside: +1,566.67%